A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
Henslee, P J
A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts. [electronic resource] - Transplantation proceedings Feb 1989 - 3004-7 p. digital
Publication Type: Case Reports; Journal Article
0041-1345
Adult
Antibodies, Monoclonal--therapeutic use
Bone Marrow Transplantation--immunology
Drug Evaluation
Graft vs Host Disease--immunology
Histocompatibility Testing
Humans
Immunotoxins--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology
Lymphocyte Depletion
Male
Postoperative Complications--prevention & control
Ricin--immunology
T-Lymphocytes
A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts. [electronic resource] - Transplantation proceedings Feb 1989 - 3004-7 p. digital
Publication Type: Case Reports; Journal Article
0041-1345
Adult
Antibodies, Monoclonal--therapeutic use
Bone Marrow Transplantation--immunology
Drug Evaluation
Graft vs Host Disease--immunology
Histocompatibility Testing
Humans
Immunotoxins--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology
Lymphocyte Depletion
Male
Postoperative Complications--prevention & control
Ricin--immunology
T-Lymphocytes